Fabrication and evaluation of captopril modified-release oral formulation

References

• Varshosaz J, Tavakoli N, Kheirolahi F. Use of hydrophilic natural gums in formulation of sustained-release matrix tablets of tramadol hydrochloride. AAPS PharmSciTech. 2006;7(1): article 24.
   Google Scholar
• Varshosaz J, Faghihian H, Rastgoo K. Preparation and characterization of metoprolol controlled-release solid dispersions. Drug Delivery. 2006;13(4):295–302.
   PubMedGoogle Scholar
• Yuasa H, Ozeki T, Kanaya Y, Oishi K, Oyake T. Application of the solid dispersion method to the controlled release of medicine – I: Controlled release of water soluble medicine by using solid dispersion. Chem Pharm Bull. 1991;39(2):465–467.
   Google Scholar
• Yuasa H, Ozeki T, Kanaya Y, Oishi K. Application of the solid dispersion method to the controlled release of medicine – II: Sustained release tablet using solid dispersion granule and the medicine release mechanism. Chem Pharm Bull. 1992;40(6):1592–1696.
   Google Scholar
• Ozeki T, Yuasa H, Kanaya Y, Oishi K. Application of the solid dispersion method to the controlled release of medicine – V: Suppression mechanism of the medicine release rate in the three-component solid dispersion system. Chem Pharm Bull. 1994;42(2):337–343.
   Google Scholar
• Ozeki T, Yuasa H, Kanaya Y, Oishi K. Application of the solid dispersion method to the controlled release of medicine – VII: Release mechanism of a highly water-soluble medicine from solid dispersion with different molecular weight of polymer. Chem Pharm Bull. 1995;43(4):660–665.
   Google Scholar
• Ozeki T, Yuasa H, Kanaya Y, Oishi K. Application of the solid dispersion method to the controlled release of medicine – VIII: Medicine release and viscosity of the hydrogel of a water-soluble polymer in a three-component solid dispersion system. Chem Pharm Bull. 1995;43(9):1574–1579.
   Google Scholar
• Gurnasinghani M, Bhatt H, Lalla J. Indomethacin delivery from matrix controlled release indomethacin tablets. J Control Release. 1989;8(3):211–222.
   Google Scholar
• Aceves J, Cruz R, Hernandez E. Preparation and characterization of furosemide-Eudragit® controlled release systems. Int J Pharm. 2000;195(1–2):45–53.
   Google Scholar
• Goracinova K, Klisarova L, Simov A. Physical characterization and dissolution properties of verapamil hydrochloride co-precipitates. Drug Dev Ind Pharm. 1995;21(3):383–391.
   Google Scholar
• Duchin K, Singhavi S, Willard D, Migdalof B, Mckinstry D. Captopril kinetics. Clin Pharmacol Ther. 1982;31(4):452–458.
   PubMedGoogle Scholar
• Seta Y, Higuchi F, Otsuka T, Kawahara Y, Nishimura K, Okada R, Koike H. Preparation and pharmacological evaluation of captopril sustained-release dosage forms using oily semisolid matrix. Int J Pharm. 1988;41(1–3):255–262.
   Google Scholar
• Seta Y, Otsuka T, Tokiwa H, Naganuma H, Kawahara Y, Nishimura K, Okada R. Design of captopril sustained-release preparation with oily semisolid matrix intended for use in human subjects. Int J Pharm. 1988;41(1–3):263–269.
   Google Scholar
• Matharu R, Singhavi N. Novel drug delivery system for captopril. Drug Dev Ind Pharm. 1992;18(14):1567–1574.
   Google Scholar
• Hongshu L. Sustained release preparation containing captopril and hydrochlorothiazide and preparation process thereof. Patent No., CN1994306; 2007.
   Google Scholar
• Woo-Hyun B, Hyun-Jong S, Hee-Sang C, Choon-Sung K. Captopril sustained release tablet. Patent No., KR960008229 (B1); 1996.
   Google Scholar
• Xue D, Hui Z, Xiangyu X. A sustained release captopril formulation having a supermolecular intercalation structure and the preparation process thereof. Patent No., WO2005067975 (A1); 2005.
   Google Scholar
• Markey M, Jenny L, John S. Extending the duration of drug release within the stomach during the fed mode. Patent No., CA2364845 (A1); 2003.
   Google Scholar
• Serajuddin A, Fakes M. Sustained release formulation containing captopril and method. US Patent No., US5433951; 1995.
   Google Scholar
• Virginia F, Zebunnissa F. Effervescent pharmaceutical formulations containing controlled release biodegradable microcapsules. Patent No., CA2187153 (A1); 1995.
   Google Scholar
• Markey M, Jenny L, John S. Gastric-retentive oral drug dosage forms for controlled release of highly soluble drugs. Patent No., CA2290624 (A1); 1998.
   Google Scholar
• Sutanata W, Craig D, Newton J. An evaluation of the mechanisms of drug release from glyceride bases. J Pharm Pharmacol. 1995;47(3):182–187.
   PubMedGoogle Scholar
• Barthelemy P, Laforet J, Farah N, Joachim J. Compritol® ATO 888: An innovative hot-melt coating agent for prolonged-release drug formations. Eur J Pharm Biopharm. 1999;47(1):87–90.
   PubMedGoogle Scholar
• Faham A, Prinderre P, Piccerelle P, Farah N, Joachim J. Hot melt coating technology: Influence of Compritol® ATO 888 and granule size on chloroquine release. Pharmazie. 2000;55(6):444–448.
   PubMedGoogle Scholar
• Mirghani A, Idkaidek N, Salem M, Najib N. Formulation and release behavior of diclofenac sodium in Compritol® ATO 888 matrix beads encapsulated in alginate. Drug Dev Ind Pharm. 2000;26(7):791–795.
   PubMed Web of Science ®Google Scholar
• Duarte A, Gordillo M, Cardoso M, Simplício A, Duarte C. Preparation of ethyl cellulose/methyl cellulose blends by supercritical antisolvent precipitation. Int J Pharm. 2006;311(1–2):50–54.
   PubMedGoogle Scholar
• Kumar V, Banker G. Chemically modified cellulosic polymers. Drug Dev Ind Pharm. 1993;19(1–2):1–31.
   Google Scholar
• Pearnchob N, Bodmeier R. Coating of pellets with micronized ethyl cellulose particles by a dry powder coating technique. Int J Pharm. 2003;268(11):1–11.
   PubMedGoogle Scholar
• Sarisuta N, Sirithunyalug J. Release rate of indomethacin from coated granules. Drug Dev Ind Pharm. 1988;14(5):683–687.
   Google Scholar
• Benita S, Donbrow M. Release kinetics of sparingly soluble drugs from theophylline microcapsules. J Pharm Pharmacol. 1982;34(2):77–82.
   PubMedGoogle Scholar
• Benita S, Babay D, Hoffman A, Donbrow M. Relation between individual and ensemble release kinetics of indomethacin from microspheres. Pharm Res. 1988;5(3):178–182.
   PubMedGoogle Scholar
• Donbrow M, Friedman M. Permeability of films of ethyl cellulose and PEG to caffeine. J Pharm Pharmacol. 1974;26(2):148–150.
   PubMedGoogle Scholar
• Shaikh N, Abidi S, Block L. Evaluation of ethyl cellulose as a matrix for prolonged release formulations:I-water-soluble drugs-acetaminophen and theophylline. Drug Dev Ind Pharm. 1987;13(8):1345–1369.
   Google Scholar
• Shaikh N, Abidi S, Block L. Evaluation of ethyl cellulose as a matrix for prolonged release formulations: II – sparingly water-soluble drugs: Ibuprofen and indomethacin. Drug Dev Ind Pharm. 1987;13(14):2495–2518.
   Google Scholar
• Emeje M, Kunle O, Ofoefule S. Compaction characteristics of ethyl cellulose in the presence of some channeling agents: Technical note. AAPS PharmSciTech. 2006;7(3): article 58.
   PubMedGoogle Scholar
• Shlieout G, Zessin G. Investigation of ethyl cellulose as a matrix former and a new method to regard and evaluate the compaction data. Drug Dev Ind Pharm. 1996;22(4):313–319.
   Web of Science ®Google Scholar
• Raj R, Daniel B. Prediction of compressive properties of closed-cell aluminum foam using artificial neural network. Computational Mat Sci. 2008;43(4):767–773.
   Google Scholar
• Mariko M, Ayako M, Kozo T, Koichi I, Tsuneji N. Improving insulin enteral absorption using water-in-oil-in water emulsion. Int J Pharm. 1998;172(1–2):189–198.
   Google Scholar
• Flashner-Barak M, Lerner I, Rosenberger V, Moldavski N. Menthol solutions of drugs. Patent No., WO/2004/073686; 2004.
   Google Scholar
• The Indian Pharmacopoeia, Govt., of India, Ministry of Health and Family Welfare, The Controller of Publication, New Delhi; 1996.
   Google Scholar
• Nokhodchi A, Hassan-Zadeh D, Monajjem-Zadeh F, Taghi-Zadeh N. Effect of various surfactants and their concentration on controlled release of captopril from polymeric matrices. Acta Pharm. 2008;58(2):151–162.
   PubMedGoogle Scholar
• Bamba M, Puisievx F, Marty J, Carstensen J. Release mechanism in gel forming sustained release formulation. Int J Pharm. 1979;2(5–6):307–315.
   Google Scholar
• Gibaldi M, Feldman S. Establishment of sink conditions in dissolution rate determination. J Pharm Sci. 1967;56(10):1238–1242.
   PubMed Web of Science ®Google Scholar
• Korsmeyer R, Gurny R, Doelker E, Buri P, Peppas N. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15(1):25–35.
   Google Scholar
• Higuchi T. Rate of release of medicaments from ointment bases containing drugs in suspensions. J Pharm Sci. 1961;50(10):874–875.
   PubMedGoogle Scholar
• Higuchi T. Mechanism of sustained-action medication: Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci. 1963;52(12):1145–1149.
   PubMed Web of Science ®Google Scholar
• Higuchi I. Analysis of data on the medicament release from ointments. J Pharm Sci. 1962;51(8):802–804.
   PubMedGoogle Scholar
• Gohel M, Parikh R, Padshala M, Sarvaiya K, Jena D. Formulation and optimization of directly compressible isoniazid modified release matrix tablet. Indian J Pharm Sci. 2007;69(5):640–645.
   Google Scholar
• Moore J, Flanner H. Mathematical comparison of dissolution profiles. Pharm Technol. 1996;20(6):64–74.
   Google Scholar
• Gohel M, Panchal M. Refinement of lower acceptance value of the similarity factor (f2) in comparison of dissolution profile. Dissolut Technol. 2002;9(1):18–22.
   Google Scholar
• Shah V, Tsong Y, Sathe P, Liu J. In vitro dissolution profile comparison statistics and analysis of the similarity factor, f2. Pharm Res. 1998;15(6):889–896.
   PubMed Web of Science ®Google Scholar
• U.S., Department of Health and Human Services, Food,and Drug Administration, Center for Drug Evaluation and Research. Guidance for Industry: Dissolution Testing of Immediate Release Solid Dosage Forms; August 1997.
   Google Scholar
• Reddy K, Mutalik S, Reddy S. Once-daily sustained-release matrix tablets of nicorandil: Formulation and in vitro evaluation. AAPS PharmSciTech. 2003;4(4): Article 61.
   PubMedGoogle Scholar
• The Indian Pharmacopoeia, Govt., of India, Ministry of Health and Family Welfare, The Controller of Publication, New Delhi; 1955.
   Google Scholar
• Handbook of Pharmaceutical Excipients. Rowe RC, Sheskey PJ, Weller PJ, editors. London: Pharmaceutical Press; 2003.
   Google Scholar
• Feng-Qian L, Jin-Hong H, Jia-Xin D, Hua S, Shu X, Ji-Yong L. In vitro controlled release of sodium ferulate from Compritol ATO 888 based matrix tablets. Int J Pharm. 2006;324(2):152–157.
   PubMedGoogle Scholar
• Levison K, Takayama K, Isowa K, Okaba K, Nagai T. Formulation optimization of indomethacin gels containing a combination of three kinds of cyclic monoterpenes as percutaneous penetration enhancers. J Pharm Sci. 1994;83(9):1367–1372.
   PubMedGoogle Scholar
• Shirakura O, Yamada M, Hashimoto M, Ishimaru S, Takayama K, Nagai T. Particle size design using computer optimization technique. Drug Dev Ind Pharm. 1991;17(4):471–483.
   Google Scholar
• Takayama K, Morva A, Fujikawa M, Hattori Y, Obata Y, Nagai T. Formula optimization of theophylline controlled release tablet based on artificial neural networks. J Control Release. 2000;68(2):175–186.
   PubMedGoogle Scholar
• Takahara J, Takayama K, Nagai T. Multi objective simultaneous optimization technique based on an artificial neural network in sustained release formulations. J Control Release. 1997;49(1):11–20.
   Google Scholar